Indefinite Delivery Contract SPE2DX17D9536

The federal contract IDV award SPE2DX17D9536 is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and held by DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The IDC was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities worldwide.

The contract covers a diverse portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. The IDC enables the DLA to issue firm fixed-price delivery orders for these pharmaceutical items, positioning DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain. The contract has an ultimate completion date of November 2026 and does not include any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards.